• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

COA Submits Comments on CMS' Proposed CAR T-Cell Coverage Decision

Article

The Community Oncology Alliance (COA) has submitted formal comments to CMS regarding the agency's proposed national coverage determination for chimeric antigen receptor (CAR) T-cell therapy.

The Community Oncology Alliance (COA) has submitted formal comments to CMS regarding the agency's proposed national coverage determination for chimeric antigen receptor (CAR) T-cell therapy, saying that while they are pleased with the direction of covering the therapy, they have concerns with the language included in the memo.

According to COA, CMS should not limit CAR T-cell coverage to hospitals, with many community oncology practices having the experience and capability to administer the therapy. Read the full comment letter.

Related Videos
Peter Voorhees, MD, Atrium Health Levine Cancer Institute
Danielle Roman, PharmD, BCOP, Allgheny Health Network
Dr Debra Patt
Ira Zackon, MD, senior medical director, Ontada
Danielle Roman, PharmD, BCOP, Allegheny Health Network
UPMC Title Slide Open | Image Credit: © Notebook and Maggie Shaw
UPMC Title Slide Open | Image Credit: © Notebook and Maggie Shaw
UPMC Title Slide Open | Image Credit: © Notebook and Maggie Shaw
Related Content
Priority Health campus | Image Credit: Priority Health

Priority Health and Group Health Cooperative of Eau Claire Finalize Transaction to Expand Access to High-Quality Care

January 6th 2026
Article

Priority Health has become the sole governing member of the Group Health Cooperative of Eau Claire, expanding its presence to 4 states and adding 61,000 Wisconsin members.

Read More

Managed Care Cast

Frameworks for Advancing Health Equity: Dental Health Care Access

December 2nd 2025
Podcast

Explore innovative strategies in dental care that are enhancing access, promoting health equity, and improving community health in Pennsylvania.

Listen

ICYMI: Highlights From COA 2025

ICYMI: Highlights From COA 2025

December 29th 2025
Article

The 2025 Community Oncology Conference, hosted by COA, reflected a commitment to patient-centered care, access, and innovation in community oncology.

Read More

Managed Care Cast logo

Transforming Addiction Care: From Stigma to Support

September 16th 2025
Podcast

On this episode of Managed Care Cast, experts discuss behavioral health services, stigma reduction, and the 4 dimensions of recovery.

Listen

Texas Oncology at state capitol | Image: Texas Oncology

Reimbursement Cuts Threaten Access to Cancer Care

December 15th 2025
Article

Oncology leaders warn that declining reimbursements and policy gaps threaten patient access and drive inequities in cancer care.

Read More

Genes | Image Credit: CrazyJuke - stock.adobe.com

Genetic Insights Shape Personalized Breast Cancer Management, Yet Variant Classification Uncertainty Persists

December 11th 2025
Article

Genetic risk models and variant tools help to guide intensive interventions for high-risk carriers and personalized management for others.

Read More

© 2026 MJH Life Sciences
AJMC®
All rights reserved.